292 related articles for article (PubMed ID: 37624574)
21. E3 ubiquitin ligase FBXW7 enhances radiosensitivity of non-small cell lung cancer cells by inhibiting SOX9 regulation of CDKN1A through ubiquitination.
Zhu H; Wang X; Zhou X; Lu S; Gu G; Liu C
Lab Invest; 2022 Nov; 102(11):1203-1213. PubMed ID: 35840806
[TBL] [Abstract][Full Text] [Related]
22. Targeting FBW7 as a Strategy to Overcome Resistance to Targeted Therapy in Non-Small Cell Lung Cancer.
Ye M; Zhang Y; Zhang X; Zhang J; Jing P; Cao L; Li N; Li X; Yao L; Zhang J; Zhang J
Cancer Res; 2017 Jul; 77(13):3527-3539. PubMed ID: 28522751
[TBL] [Abstract][Full Text] [Related]
23. Recent advances in SCF ubiquitin ligase complex: Clinical implications.
Zheng N; Zhou Q; Wang Z; Wei W
Biochim Biophys Acta; 2016 Aug; 1866(1):12-22. PubMed ID: 27156687
[TBL] [Abstract][Full Text] [Related]
24. The Fbw7 tumor suppressor regulates nuclear factor E2-related factor 1 transcription factor turnover through proteasome-mediated proteolysis.
Biswas M; Phan D; Watanabe M; Chan JY
J Biol Chem; 2011 Nov; 286(45):39282-9. PubMed ID: 21953459
[TBL] [Abstract][Full Text] [Related]
25. Thiazolidinediones modulate the expression of beta-catenin and other cell-cycle regulatory proteins by targeting the F-box proteins of Skp1-Cul1-F-box protein E3 ubiquitin ligase independently of peroxisome proliferator-activated receptor gamma.
Wei S; Lin LF; Yang CC; Wang YC; Chang GD; Chen H; Chen CS
Mol Pharmacol; 2007 Sep; 72(3):725-33. PubMed ID: 17569795
[TBL] [Abstract][Full Text] [Related]
26. The two faces of FBW7 in cancer drug resistance.
Wang Z; Fukushima H; Gao D; Inuzuka H; Wan L; Lau AW; Liu P; Wei W
Bioessays; 2011 Nov; 33(11):851-9. PubMed ID: 22006825
[TBL] [Abstract][Full Text] [Related]
27. Ubiquitination-mediated degradation of cell cycle-related proteins by F-box proteins.
Zheng N; Wang Z; Wei W
Int J Biochem Cell Biol; 2016 Apr; 73():99-110. PubMed ID: 26860958
[TBL] [Abstract][Full Text] [Related]
28. Negative regulation of the stability and tumor suppressor function of Fbw7 by the Pin1 prolyl isomerase.
Min SH; Lau AW; Lee TH; Inuzuka H; Wei S; Huang P; Shaik S; Lee DY; Finn G; Balastik M; Chen CH; Luo M; Tron AE; Decaprio JA; Zhou XZ; Wei W; Lu KP
Mol Cell; 2012 Jun; 46(6):771-83. PubMed ID: 22608923
[TBL] [Abstract][Full Text] [Related]
29. Tumor suppressor functions of FBW7 in cancer development and progression.
Wang Z; Inuzuka H; Zhong J; Wan L; Fukushima H; Sarkar FH; Wei W
FEBS Lett; 2012 May; 586(10):1409-18. PubMed ID: 22673505
[TBL] [Abstract][Full Text] [Related]
30. Proteasomal degradation of the tumour suppressor FBW7 requires branched ubiquitylation by TRIP12.
Khan OM; Almagro J; Nelson JK; Horswell S; Encheva V; Keyan KS; Clurman BE; Snijders AP; Behrens A
Nat Commun; 2021 Apr; 12(1):2043. PubMed ID: 33824312
[TBL] [Abstract][Full Text] [Related]
31. E3 ubiquitin ligase Fbw7 negatively regulates granulocytic differentiation by targeting G-CSFR for degradation.
Lochab S; Pal P; Kapoor I; Kanaujiya JK; Sanyal S; Behre G; Trivedi AK
Biochim Biophys Acta; 2013 Dec; 1833(12):2639-2652. PubMed ID: 23820376
[TBL] [Abstract][Full Text] [Related]
32. Sensitivity to antitubulin chemotherapeutics is regulated by MCL1 and FBW7.
Wertz IE; Kusam S; Lam C; Okamoto T; Sandoval W; Anderson DJ; Helgason E; Ernst JA; Eby M; Liu J; Belmont LD; Kaminker JS; O'Rourke KM; Pujara K; Kohli PB; Johnson AR; Chiu ML; Lill JR; Jackson PK; Fairbrother WJ; Seshagiri S; Ludlam MJ; Leong KG; Dueber EC; Maecker H; Huang DC; Dixit VM
Nature; 2011 Mar; 471(7336):110-4. PubMed ID: 21368834
[TBL] [Abstract][Full Text] [Related]
33. FBW7 mutations mediate resistance of colorectal cancer to targeted therapies by blocking Mcl-1 degradation.
Tong J; Tan S; Zou F; Yu J; Zhang L
Oncogene; 2017 Feb; 36(6):787-796. PubMed ID: 27399335
[TBL] [Abstract][Full Text] [Related]
34. FBW7 suppression leads to SOX9 stabilization and increased malignancy in medulloblastoma.
Suryo Rahmanto A; Savov V; Brunner A; Bolin S; Weishaupt H; Malyukova A; Rosén G; Čančer M; Hutter S; Sundström A; Kawauchi D; Jones DT; Spruck C; Taylor MD; Cho YJ; Pfister SM; Kool M; Korshunov A; Swartling FJ; Sangfelt O
EMBO J; 2016 Oct; 35(20):2192-2212. PubMed ID: 27625374
[TBL] [Abstract][Full Text] [Related]
35. The Role of FBXW7 in Gynecologic Malignancies.
Di Fiore R; Suleiman S; Drago-Ferrante R; Subbannayya Y; Suleiman S; Vasileva-Slaveva M; Yordanov A; Pentimalli F; Giordano A; Calleja-Agius J
Cells; 2023 May; 12(10):. PubMed ID: 37408248
[TBL] [Abstract][Full Text] [Related]
36. E3 Ubiquitin Ligase Fbw7 Negatively Regulates Osteoblast Differentiation by Targeting Runx2 for Degradation.
Kumar Y; Kapoor I; Khan K; Thacker G; Khan MP; Shukla N; Kanaujiya JK; Sanyal S; Chattopadhyay N; Trivedi AK
J Biol Chem; 2015 Dec; 290(52):30975-87. PubMed ID: 26542806
[TBL] [Abstract][Full Text] [Related]
37. Tumor suppression by the Fbw7 ubiquitin ligase: mechanisms and opportunities.
Davis RJ; Welcker M; Clurman BE
Cancer Cell; 2014 Oct; 26(4):455-64. PubMed ID: 25314076
[TBL] [Abstract][Full Text] [Related]
38. Polo-like Kinase-1 Regulates Myc Stabilization and Activates a Feedforward Circuit Promoting Tumor Cell Survival.
Xiao D; Yue M; Su H; Ren P; Jiang J; Li F; Hu Y; Du H; Liu H; Qing G
Mol Cell; 2016 Nov; 64(3):493-506. PubMed ID: 27773673
[TBL] [Abstract][Full Text] [Related]
39. An innate pathogen sensing strategy involving ubiquitination of bacterial surface proteins.
Apte S; Bhutda S; Ghosh S; Sharma K; Barton TE; Dibyachintan S; Sahay O; Roy S; Sinha AR; Adicherla H; Rakshit J; Tang S; Datey A; Santra S; Joseph J; Sasidharan S; Hammerschmidt S; Chakravortty D; Oggioni MR; Santra MK; Neill DR; Banerjee A
Sci Adv; 2023 Mar; 9(12):eade1851. PubMed ID: 36947610
[TBL] [Abstract][Full Text] [Related]
40. The FBXW7-NOTCH interactome: A ubiquitin proteasomal system-induced crosstalk modulating oncogenic transformation in human tissues.
Kar R; Jha SK; Ojha S; Sharma A; Dholpuria S; Raju VSR; Prasher P; Chellappan DK; Gupta G; Kumar Singh S; Paudel KR; Hansbro PM; Kumar Singh S; Ruokolainen J; Kesari KK; Dua K; Jha NK
Cancer Rep (Hoboken); 2021 Aug; 4(4):e1369. PubMed ID: 33822486
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
